Magaya’s HIV “Cure” Must Undergo Clinical Trials, At The Moment There Is No Cure: National Aids Council

The National Aids Council (NAC) has said that Prophetic Healing and Deliverance Ministries leader Walter Magaya must subject his herbs which he claims can cure HIV and Aids to rigorous tests. NAC said that Magaya’s drugs must undergo clinical trials before it can be approved. Yesterday, Magaya claimed he had found a cure for HIV and Ais after he conducted two years worth of research together with his Indian partners.

National Aids Council chief executive officer Tapuwa Magure told NewsDay

I have just heard the prophet’s assertions. Every clinical trial or experiment on human beings has to undergo rigorous tests before it is approved by the medical research council of a country, including Zimbabwe. The studies must be ethical, not exploiting the subjects and not subjecting them to poisons.

I am not aware of any such clinical trial having being approved in Zimbabwe and also of any such study having gone on here. The prophet must really provide all this data to prove that a scientific trial has really taken place and show the results…so far, there is no cure for HIV

More: NewsDay

Back to top

One Comment on “Magaya’s HIV “Cure” Must Undergo Clinical Trials, At The Moment There Is No Cure: National Aids Council

  1. Good point. But it is better still to propose joining hands with the Prophet as this is a commonly shared breakthrough. You seem to have reservations arguing much on procedures but again pursuit of procedures alone does not guarantee the drug authenticity but the tests already undergone are an absolute testimony of the drug as an authentic product that will bring a revolution in the medical sciences.

Write a Comment

Your email address will not be published.

RSS Recent Profiles Created

Satisfaction survey
How likely is it that you would recommend Pindula News to a friend or colleague?
SuggestionsHow can we improve?
You have already submitted your feedback. If you would like to add more feedback please write us on